More than 50 years of service
to Turkish Industries
Business development
The division has the mission to provide to the local pharmaceutical companies the
international support for their business development as well as represents an intelligence base for foreign companies to penetrate the Turkish market.
a) Original new patented products
Thanks to our international contacts we can search for new patented molecules fitting with your product program and assist you on the negotiation of the relevant license agreement. We also have an interesting portfolio of oncologic products.
b) Drug delivery systems
To maximize the potentiality of your products and diversify them from the competitors, original delivery systems are available or can be contract developed from specialized companies. For example bucca/gengival, mucosal delivery, slow release or fast dissolving dosage forms, etc.
c) Financial participation
To provide the financial and scientific support for the development of your company we can introduce to you potential partners interested to pave their way to enter into the Turkish market.
d) Globalization
Turkey is soon joining the European Union. The Turkish companies have to think to enlarge their operation to the EU establishing their subsidiaries or proper ties with EU companies. We can prepare feasibility studies and propose solutions and partners.
e) Diversification
Companies interested to diversify their activities distributing diagnostics, medical devices, OTC, instruments, etc. can profit of our support to identify the proper principals and nego tiate the relevant agreements.
f) Liaison office
The division provides the necessary feasibility studies and business intelligence to foreign companies interested to enter into the Turkish market.
g) Trade-marks and registrations brokerage
Foreign companies entering the Turkish market need a minimum product list to start-up. KURA LTD can look for acquisitions of products (i.e. turnovers) from local companies .
h) Other
a) Original new patented products
Thanks to our international contacts we can search for new patented molecules fitting with your product program and assist you on the negotiation of the relevant license agreement. We also have an interesting portfolio of oncologic products.
b) Drug delivery systems
To maximize the potentiality of your products and diversify them from the competitors, original delivery systems are available or can be contract developed from specialized companies. For example bucca/gengival, mucosal delivery, slow release or fast dissolving dosage forms, etc.
c) Financial participation
To provide the financial and scientific support for the development of your company we can introduce to you potential partners interested to pave their way to enter into the Turkish market.
d) Globalization
Turkey is soon joining the European Union. The Turkish companies have to think to enlarge their operation to the EU establishing their subsidiaries or proper ties with EU companies. We can prepare feasibility studies and propose solutions and partners.
e) Diversification
Companies interested to diversify their activities distributing diagnostics, medical devices, OTC, instruments, etc. can profit of our support to identify the proper principals and nego tiate the relevant agreements.
f) Liaison office
The division provides the necessary feasibility studies and business intelligence to foreign companies interested to enter into the Turkish market.
g) Trade-marks and registrations brokerage
Foreign companies entering the Turkish market need a minimum product list to start-up. KURA LTD can look for acquisitions of products (i.e. turnovers) from local companies .
h) Other
